The U.S. is moving into uncharted territory as the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) move ahead on their recent agreement.
European countries, including the United Kingdom, Germany and Austria, often have similar agreements with nonpartisan agencies.
“The ICER assessments are neither specific to veterans nor the particular characteristics of the VA health care system,” Health Affairs’ Robert Dubois writes in the post. “As the VA considers how to use this information, caution is warranted.”
The VA, according to Health Affairs, has a “very restrictive” formulary, with only 59 percent of the U.S.’s top 200 drugs in their coverage.